首页> 外文OA文献 >Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence.
【2h】

Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence.

机译:对患有压力性尿失禁的女性进行非手术治疗的有效性和成本效益的系统评价和经济模型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVES: To assess the clinical effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence (SUI) through systematic review and economic modelling. DATA SOURCES: The Cochrane Incontinence Group Specialised Register, electronic databases and the websites of relevant professional organisations and manufacturers, and the following databases: CINAHL, EMBASE, BIOSIS, Science Citation Index and Social Science Citation Index, Current Controlled Trials, ClinicalTrials.gov and the UKCRN Portfolio Database. STUDY SELECTION: The study comprised three distinct elements. (1) A survey of 188 women with SUI to identify outcomes of importance to them (activities of daily living; sex, hygiene and lifestyle issues; emotional health; and the availability of services). (2) A systematic review and meta-analysis of non-surgical treatments for SUI to find out which are most effective by comparing results of trials (direct pairwise comparisons) and by modelling results (mixed-treatment comparisons - MTCs). A total of 88 randomised controlled trials (RCTs) and quasi-RCTs reporting data from 9721 women were identified, considering five generic interventions [pelvic floor muscle training (PFMT), electrical stimulation (ES), vaginal cones (VCs), bladder training (BT) and serotonin-noradrenaline reuptake inhibitor (SNRI) medications], in many variations and combinations. Data were available for 37 interventions and 68 treatment comparisons by direct pairwise assessment. Mixed-treatment comparison models compared 14 interventions, using data from 55 trials (6608 women). (3) Economic modelling, using a Markov model, to find out which combinations of treatments (treatment pathways) are most cost-effective for SUI. DATA EXTRACTION: Titles and abstracts identified were assessed by one reviewer and full-text copies of all potentially relevant reports independently assessed by two reviewers. Any disagreements were resolved by consensus or arbitration by a third person. RESULTS: Direct pairwise comparison and MTC analysis showed that the treatments were more effective than no treatment. Delivering PFMT in a more intense fashion, either through extra sessions or with biofeedback (BF), appeared to be the most effective treatment [PFMT extra sessions vs no treatment (NT) odds ratio (OR) 10.7, 95% credible interval (CrI) 5.03 to 26.2; PFMT + BF vs NT OR 12.3, 95% CrI 5.35 to 32.7]. Only when success was measured in terms of improvement was there evidence that basic PFMT was better than no treatment (PFMT basic vs NT OR 4.47, 95% CrI 2.03 to 11.9). Analysis of cost-effectiveness showed that for cure rates, the strategy using lifestyle changes and PFMT with extra sessions followed by tension-free vaginal tape (TVT) (lifestyle advice-PFMT extra sessions-TVT) had a probability of greater than 70% of being considered cost-effective for all threshold values for willingness to pay for a QALY up to 50,000 pounds. For improvement rates, lifestyle advice-PFMT extra sessions-TVT had a probability of greater than 50% of being considered cost-effective when society's willingness to pay for an additional QALY was more than 10,000 pounds. The results were most sensitive to changes in the long-term performance of PFMT and also in the relative effectiveness of basic PFMT and PFMT with extra sessions. LIMITATIONS: Although a large number of studies were identified, few data were available for most comparisons and long-term data were sparse. Challenges for evidence synthesis were the lack of consensus on the most appropriate method for assessing incontinence and intervention protocols that were complex and varied considerably across studies. CONCLUSIONS: More intensive forms of PFMT appear worthwhile, but further research is required to define an optimal form of more intensive therapy that is feasible and efficient for the NHS to provide, along with further definitive evidence from large, well-designed studies.
机译:目的:通过系统评价和经济模型评估非手术治疗应激性尿失禁(SUI)妇女的临床疗效和成本效益。数据来源:Cochrane失禁小组专业注册簿,电子数据库以及相关专业组织和制造商的网站,以及以下数据库:CINAHL,EMBASE,BIOSIS,科学引文索引和社会科学引文索引,当前对照试验,ClinicalTrials.gov和UKCRN投资组合数据库。研究选择:研究包括三个不同的要素。 (1)对188名SUI妇女的调查,以确定对她们重要的结果(日常生活活动,性别,卫生和生活方式问题,情绪健康以及服务的可用性)。 (2)对SUI的非手术治疗进行系统的回顾和荟萃分析,以通过比较试验结果(直接成对比较)和建模结果(混合治疗比较-MTC)来找出最有效的方法。考虑五种通用干预措施[骨盆底肌肉训练(PFMT),电刺激(ES),阴道锥(VCs),膀胱训练(),共确定了88项来自9721名妇女的随机对照试验(RCT)和准RCT报告数据。 BT)和5-羟色胺去甲肾上腺素再摄取抑制剂(SNRI)药物],并且有许多变体和组合。通过直接成对评估可获得37项干预措施和68项治疗比较的数据。混合治疗比较模型使用55个试验(6608名妇女)的数据比较了14种干预措施。 (3)使用马尔可夫模型进行经济建模,以找出哪种治疗组合(治疗途径)对于SUI最具成本效益。数据提取:由一名审阅者对确定的标题和摘要进行评估,由两名审阅者对所有潜在相关报告的全文进行独立评估。任何分歧均由第三方以协商一致或仲裁方式解决。结果:直接成对比较和MTC分析表明治疗比不治疗更有效。通过额外的疗程或通过生物反馈(BF)以更密集的方式提供PFMT似乎是最有效的治疗方法[PFMT额外疗程与未治疗(NT)的优势比(OR)为10.7,可信区间为95%(CrI) 5.03至26.2; PFMT + BF vs NT OR 12.3,95%CrI 5.35至32.7]。仅当以改善为衡量标准时,才有证据表明基本PFMT比没有治疗更好(PFMT基本vs NT OR 4.47,95%CrI 2.03至11.9)。成本效益分析表明,对于治愈率,使用生活方式改变和PFMT进行额外治疗,然后再使用无张力阴道胶带(TVT)(生活方式建议-PFMT额外治疗-TVT)的策略的治愈率大于70%对于愿意支付最高50,000磅QALY的所有阈值,被认为具有成本效益。对于改善率,当社会愿意支付额外QALY超过10,000英镑时,生活方式建议-PFMT额外会期-TVT有超过50%被认为具有成本效益的可能性。结果对PFMT的长期性能变化以及基本PFMT和PFMT加额外课程的相对有效性最敏感。局限性:尽管确定了大量研究,但大多数比较的可用数据很少,长期数据稀疏。证据合成面临的挑战是,在评估失禁和干预方案的最合适方法上缺乏共识,这些方法在研究中非常复杂且差异很大。结论:PFMT的强化形式似乎是值得的,但是需要进一步的研究来确定一种最佳的强化治疗形式,这对于NHS是可行和有效的,以及来自大型,精心设计的研究的进一步明确证据。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号